CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker

被引：4
|
作者：
Li, Cuicui [1 ]
Zhang, Litian [1 ]
Jin, Qiqi [1 ]
Jiang, Haoyun [1 ]
Wu, Chongyang [1 ]
机构：
[1] Lanzhou Univ, Dept Gastroenterol, Hosp 2, Lanzhou 730000, Peoples R China
来源：
BIOMARKERS IN MEDICINE | 2023年 / 17卷 / 12期
基金：
中国国家自然科学基金;
关键词：
adenosine; biomarker; CD39; CD8(+) TIL; exhaustion; immunosuppression; PD-1; tumor microenvironment; CD8; T-CELLS; ECTONUCLEOTIDASES CD39; IMMUNE-RESPONSES; PD-L1; EXPRESSION; ADENOSINE; RECEPTOR; CD73; METABOLISM; SUBSETS; CANCER;
D O I：
10.2217/bmm-2023-0202
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
As a regulator of the dynamic balance between immune-activated extracellular ATP and immunosuppressive adenosine, CD39 ectonucleotidase impairs the ability of immune cells to exert anticancer immunity and plays an important role in the immune escape of tumor cells within the tumor microenvironment. In addition, CD39 has been studied in cancer patients to evaluate the prognosis, the efficacy of immunotherapy (e.g., PD-1 blockade) and the prediction of recurrence. This article reviews the importance of CD39 in tumor immunology, summarizes the preclinical evidence on targeting CD39 to treat tumors and focuses on the potential of CD39 as a biomarker to evaluate the prognosis and the response to immune checkpoint inhibitors in tumors.
引用
收藏
页码：563 / 576
页数：14
相关论文
共 50 条
  • [41] CD39/ENTPD1 is protective in a model of biliary fibrosis and modulates CD8+T cell gut-homing via α4β7 integrin
    Rothweiler, Sonja
    Peng, Zhen-Wei
    Liu, Susan B.
    Ikenaga, Naoki
    Popov, Yury
    Robson, Simon C.
    HEPATOLOGY, 2015, 62 : 619A - 620A
  • [42] CD39: the potential target in small cell lung cancer
    Chen, Shanhao
    Wu, Shengyu
    Zhang, Liping
    Zhang, Wei
    Liu, Yu
    Chen, Bin
    Zhao, Sha
    Li, Wei
    Sun, Chenglong
    Wang, Lei
    Jia, Keyi
    Wang, Hao
    Chen, Peixin
    Wu, Chunyan
    Zhu, Junjie
    He, Yayi
    Zhou, Caicun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1483 - +
  • [43] The therapeutic potential of CD39: Interview with Dr Simon Robson
    Quigley, Emma
    Robson, Simon C.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (05) : 649 - 652
  • [44] A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model
    Adhikary, Sam R.
    Cuthbertson, Peter
    Turner, Ross J.
    Sluyter, Ronald
    Watson, Debbie
    IMMUNOLOGY AND CELL BIOLOGY, 2020, 98 (05): : 397 - 410
  • [45] ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer (vol 2, 106, 2022)
    Rocconi, Rodney P.
    Stanbery, Laura
    Tang, Min
    da Silva, Luciana Madeira
    Walter, Adam
    Monk, Bradley J.
    Herzog, Thomas J.
    Coleman, Robert L.
    Manning, Luisa
    Wallraven, Gladice
    Horvath, Staci
    Bognar, Ernest
    Senzer, Neil
    Brun, Scott
    Nemunaitis, John
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [46] ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Cell Carcinoma
    Whitley, Melodi Javid
    Suwanpradid, Jutamas
    Lai, Chester
    Jiang, Simon W.
    Cook, Jonathan L.
    Zelac, Daniel E.
    Rudolph, Ross
    Corcoran, David L.
    Degan, Simone
    Spasojevic, Ivan
    Levinson, Howard
    Erdmann, Detlev
    Reid, Claire
    Zhang, Jennifer Y.
    Robson, Simon C.
    Healy, Eugene
    Havran, Wendy L.
    Macleod, Amanda S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : 2509 - 2520
  • [47] Disordered purinergic signaling inhibits pathological angiogenesis in Cd39/Entpd1-null mice
    Jackson, Shaun W.
    Hoshi, Tomokazu
    Wu, Yan
    Sun, Xiaofeng
    Enjyoji, Keiichi
    Cszimadia, Eva
    Sundberg, Christian
    Robson, Simon C.
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (04): : 1395 - 1404
  • [48] CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma
    Hayes, Gregory M.
    Cairns, Belinda
    Levashova, Zoia
    Chinn, Lawrence
    Perez, Myra
    Theunissen, Jan-Willem
    Liao-Chan, Sindy
    Bermudez, Abel
    Flory, Mark R.
    Schweighofer, Karl J.
    van der Horst, Edward H.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (06): : 1181 - 1188
  • [49] Identification of ENTPD1 as a novel biomarker linking allergic rhinitis and systemic lupus erythematosus
    Chen, Min
    Meng, Yingdi
    Shi, Xiaoqiong
    Zhu, Chengjing
    Zhu, Minhui
    Tang, Haihong
    Zheng, Hongliang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors
    Petar Rasic
    Maja Jovanovic-Tucovic
    Marija Jeremic
    Slavisa M Djuricic
    Zorica V Vasiljevic
    Maja Milickovic
    Djordje Savic
    World Journal of Gastrointestinal Oncology, 2021, 13 (08) : 799 - 821
12345